Ziyin Zhang
Wuhan, 430030, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications
Correction: Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 31, 2026
WHAMM deficiency alters splenic B-cell populations, BCR signaling, and actin remodeling.
Journal: Molecular medicine (Cambridge, Mass.)
Published: March 13, 2026
Associations between cholesterol, high-density lipoprotein, and glucose index and hyperuricemia in patients with diabetes.
Journal: BMC endocrine disorders
Published: January 28, 2026
Ring finger protein 213 regulates B-cell receptor signaling, metabolism, and development in B lymphocytes.
Journal: Signal transduction and targeted therapy
Published: September 03, 2025
A Focus on the Mechanisms of Alteration in Host Lymphocyte Level Following Severe Fever with Thrombocytopenia Syndrome Virus (SFTSV) Infection.
Journal: Journal of inflammation research
Published: March 28, 2025
STAT3 regulates NK and NKT cell differentiation through C-X3-C motif chemokine receptor 1 (CX3CR1) in hyper-IgE syndrome.
Journal: Molecular biomedicine
Published: December 21, 2024
Mitochondrial SIRT2-mediated CPT2 deacetylation prevents diabetic cardiomyopathy by impeding cardiac fatty acid oxidation.
Journal: International journal of biological sciences
Published: August 26, 2024
Efficacy of rituximab in treating steroid-resistant Graves' orbitopathy in active moderate-to-severe and sight-threatening forms: A retrospective observation from China.
Journal: Heliyon
Published: December 29, 2023
Exendin-4 ameliorates tau hyperphosphorylation and cognitive impairment in type 2 diabetes through acting on Wnt/β-catenin/NeuroD1 pathway.
Journal: Molecular medicine (Cambridge, Mass.)
Published: June 15, 2023
TRIB2-Mediated Modulation of AMPK Promotes Hepatic Insulin Resistance.
Journal: Diabetes
Published: March 09, 2023
Non-obese NAFLD had no better cardio-metabolic risk profile than obese NAFLD in type 2 diabetic patients.
Journal: Cardiovascular diabetology
Published: June 19, 2022
Showing 1-12 of 12
Last Updated: 09/26/2026